SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Trading Cabana
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RockyBalboa who wrote (3683)6/30/2008 3:51:36 PM
From: RockyBalboa  Read Replies (1) of 6370
 
THis is what analysts say:


Citi analyst Lucy Lu said she thinks the company's core molecular diagnostics business is worth $50 per share. She maintained a "Hold" rating on the stock. Cowen analyst Ian Sanderson said the stock could trade in the low $40-range, and Michael Yee of RBC Capital Markets predicted a "near-term valuation floor" of $37 per share.

Lu had said there was less than a 10 percent chance the trial would be successful, and Sanderson was only slightly more optimistic...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News